Financial Interest Index

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest, and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.

First

Last

Commercial Interest

Anthony

Aldave

Eye Bank Association of America: Scientific/Medical Advisory Board Member

Peter

Bedard

University of Minnesota: Patent Holder
BrightStar Therapeutics: Patent Holder

Lorenzo

Cervantes

Eversight: Scientific/Medical Advisory Board Member
Eversight: Corporate Board Member

Clara

Chan

Allergan: Speakers Bureau
Alcon:Speakers Bureau
Bausch and Lomb: Speakers Bureau
Aequus: Consultant
Santen: Consultant
Tearlab: Research Grant Site Principal Investigator
Johnson and Johnson: Consultant
Zeiss: Consultant
Labtician: Speakers Bureau
Thea: Consultant
Novartis: Speakers Bureau
Sun Pharmaceuticals: Consultant

David

Chu

Abbvie, Aldeyra, Mallinckrodt, Santen, Dompe: Consultant
Mallinckrodt: Speakers Bureau, Research Grant Overall Principal Investigator
Abbvie, Aldeyra, Gilead,M allinckrodt, Santen, Tarsius: Other Financial or Material Support

Marjan

Farid

Johnson and Johnson Vision: Consultant
Allergan: Consultant
CorneaGen: Consultant
Dompe: Consultant
Biotissue: Consultant
Zeiss: Consultant
Bausch and Lomb: Consultant
Novartis: Consultant
KALA: Consultant

Asim

Farooq

GlaxoSmithKline: Consultant

Pedram

Hamrah

Dompe: Research Grant Site Principal Investigator
Coopervision: Research Grant Site Principal Investigator
Shire: Research Grant Site Principal Investigator
Allergan: Research Grant Site Principal Investigator
OKYO: Research Grant Site Principal Investigator
National Eye Institute: Research Grant Site Principal Investigator
Santen: Consultant
Ocunova: Consultant
OKYO: Consultant
Novartis: Research Grant Overall Principal Investigator
Novaliq: Scientific/Medical Advisory Board Member
Dompe: Scientific/Medical Advisory Board Member

Sadeer

Hannush

Kowa, Inc: Consultant

Erik

Hellier

Eversight: Employee

Joshua

Hou

Brightstar Therapeutics: Patent Holder

Adam

Kaufman

Alcon: Consultant
1800Contacts: Consultant
Bausch & Lomb: Consultant

Caithlin

Lopes

Eversight: Employee

Marian

Macsai

Trefoil: Consultant
Allergan: Consultant
Inversa: Consultant
Glaukos: Scientific/Medical Advisory Board Member
Novartis: Speakers Bureau
Bruder: Scientific/Medical Advisory Board Member
Eyevance: Stock Shareholder
Oyster Point Pharma: Employee

Priya

Mathews

W. L. Gore and Associates: Consultant
Sun Pharmaceutical: Speakers Bureau

Gerrit

Melles

DORC International/Dutch Ophthalmic USA: Consultant

SurgiCube International: Consultant

Shahzad

Mian

KOWA: Research Grant Site Principal Investigator
VisionCare: Research Grant Site Principal Investigator
DOD: Research Grant Site Principal Investigator

Sudeep

Pramanik

Eyedea Medical: Stock Shareholder

Francis

Price

Haag-Streit: Consultant
Aerie Pharmaceuticals: Consultant
Alcon: Consultant
Allergan: Consultant
Eyepoint: Consultant

Michelle K.

Rhee

Ocular Therapeutix: Research Grant Site Principal Investigator
NovaBay: Scientific/Medical Advisory Board Member

Christine

Shieh

GSK: Consultant

Divya

Srikumaran

AAO Hoskins Center/ Iris Registry Grant: Research Grant Site Principal Investigator
Alcon: Consultant

Michael

Szkarlat

Eversight: Employee

Mark

Terry

Bausch and Lomb Surgical: Patent Holder
Moria: Unrestricted Educational Grant for Annual EKG Breakfast

Michael

Titus

Eversight: Employee

Elmer

Tu

Eversight: Scientific/Medical Advisory Board Member
GSK: Consultant
Dompe: Consultant